Asbury Automotive (ABG) Q4 2025 earnings review
Record Revenue Masked by Impairments and Organic Declines
Asbury reported record annual revenue of $18B and Q4 revenue of $4.7B (+4% YoY), driven largely by acquisitions (Herb Chambers). However, the surface growth hides organic weakness: Same Store Revenue fell 6% and Adjusted EPS declined 10% YoY to $6.67. GAAP Net Income collapsed 53% due to significant non-cash asset impairments ($115M) and divestiture impacts. While Parts & Service remains a fortress (+12% revenue), rising SG&A expenses and normalizing new vehicle margins are compressing profitability.
🐂 Bull Case
Fixed operations remain the company's backbone. Parts & Service revenue grew 12% YoY (2% Same Store) with gross margins expanding 102 bps to 58.6%. This high-margin segment now accounts for 48.7% of total gross profit.
Despite a 4% volume drop in used retail units, Asbury prioritized pricing power. Used Retail Gross Profit grew 16% YoY, and GPU (Gross Profit per Unit) surged 21% to $1,758, marking a strategic shift from volume to value.
🐻 Bear Case
Acquisitions are masking core weakness. Same Store Revenue declined 6% YoY, with New Vehicle revenue down 6% and Used Retail revenue down 10%. Without the M&A lift, the business is shrinking.
SG&A as a percentage of Gross Profit deteriorated significantly, rising 307 bps to 66.7% (GAAP) and 230 bps to 65.3% (Adjusted). Rising costs are outpacing gross profit growth, squeezing operating margins down to 2.7% (GAAP) from 5.3% a year ago.
⚖️ Verdict: ⚪
Neutral. The shift to higher-margin Parts & Service and Used profitability is encouraging, but the -6% organic revenue decline and rising SG&A ratio suggest the core business is facing headwinds that acquisitions can't fully hide.
Key Themes
Asset Impairments & Write-downs
Asbury took a massive hit to GAAP earnings via $115M in asset impairments (vs $14M prior year), primarily related to write-downs of dealership franchise rights. While non-cash, this signals that previous acquisitions or specific store assets are performing below modeled expectations.
Parts & Service Margin Expansion
P&S continues to accelerate as the primary profit engine. Not only did revenue grow 12%, but gross profit grew 13%, outpacing sales. The margin expansion to 58.6% (+102 bps) demonstrates pricing power and operational efficiency in the service bays, offsetting new vehicle weakness.
New Vehicle Margin Normalization
Decelerating. New vehicle PVR (Per Vehicle Retailed) gross profit fell 8% YoY to $3,344. While volumes were flat (-0.1% total), the profitability per unit is sliding back toward historical norms as inventory supply improves (Days Supply rose to 52 from 49).
Portfolio Optimization
Asbury is actively churning its portfolio. In Q4, they divested four stores (estimated $150M annualized revenue) while continuing to integrate the massive Herb Chambers acquisition. This churn complicates YoY comparisons but reflects a strategy to shed underperforming assets to manage leverage.
SG&A De-leverage
Adjusted SG&A as a % of Gross Profit spiked to 65.3%, significantly higher than the 63.0% reported a year ago. Management cited Tekion implementation expenses ($5M) as a factor, but the magnitude of the increase suggests broader inflationary pressures on wages and operations relative to gross profit generation.
Other KPIs
Decelerating. A sharp contrast to the reported +4% total revenue growth. This indicates that the core business (excluding recent M&A) is contracting, with declines across New (-6%) and Used (-10%) vehicle sales.
Stable/Accelerating. Up 4% YoY ($2,236 in 24Q4). Despite high interest rates and affordability challenges, the Finance & Insurance segment remains resilient, extracting more value per transaction.
Stable. Ended the year at 3.2x, consistent with 25Q3 levels. Management noted they ended 'ahead of our leverage forecast,' implying they expected to be more levered post-acquisition.
Guidance
Management continues to emphasize 'balanced capital allocation.' They repurchased $50M in shares in Q4 (vs $183M total for FY24). $176M remains on the authorization. No specific FY26 quantitative guidance was provided in the release text.
Key Questions
Impairment Specifics
The $115M in Q4 asset impairments is substantial. Which specific franchises or regions drove this write-down, and does this signal a structural impairment in the long-term value of those assets?
SG&A Trajectory
With Adjusted SG&A/Gross Profit hitting 65.3% (above the 'mid-60s' target discussed in prior quarters), how much of this is structural vs. temporary transition costs from Tekion? When do we return to leverage?
Organic Growth Turnaround
Same-store revenue dropped 6% this quarter. Beyond the Herb Chambers acquisition, what is the plan to stabilize and grow the organic footprint in FY26?